Company intelligence / Profile preview

Anhui Shuangke Pharmaceutical

Ownership: Private
Development stage: Other

Overview

Anhui Shuangke Pharmaceutical is a leading Chinese ophthalmic pharmaceutical manufacturer with 15 commercialized eye drop products across multiple indications. The company has developed several nationally exclusive or first-to-market drugs in China, including both chemical entities and traditional Chinese medicines. It operates GMP-certified facilities with large-scale production capacity and is recognized as an innovator in the domestic ophthalmology market.

Therapeutic areas: OphthalmologyImmunologyInfectious Diseases
Modalities: Small moleculeTraditional Chinese medicineBiologic
Industry: Biotech

Partnerships

YENHE Company (equipment partnership)

Beyond the preview

Go deeper on Anhui Shuangke Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anhui Shuangke Pharmaceutical.

Explore the full profile